探讨胰酶肠溶胶囊对酒精性脂肪肝合并消化不良的临床疗效.docVIP

精品论文 参考文献 探讨胰酶肠溶胶囊对酒精性脂肪肝合并消化不良的临床疗效 拜泉县人民医院 164700 【摘 要】目的 探讨并分析对酒精性脂肪肝合并消化不良患者采用胰酶肠溶胶囊进行治疗的临床效果。方法 此次研究的对象是选取2012年5月～2014年5月到我院进行治疗的106例酒精性脂肪肝合并消化不良患者，将其临床资料进行回顾性分析，并随机平均分成研究组与对照组，给予对照组患者常规的多烯磷脂酰胆碱进行治疗，对于研究组患者则在对照组的基础上增加胰酶肠溶胶囊进行治疗。结果 研究组总有效率高达94.34%，明显高于对照组79.25%（Plt;0.05）；患者的症状积分由治疗前的（8.4plusmn;3.1）分下降至（3.4plusmn;1.1）分，差值明显优于对照组，组间数据差异性显著（Plt;0.05）；不良反应的发生率研究组为7.55%，明显低于对照组（18.87%），组间数据差异性显著（Plt;0.05）。结论 在对酒精性脂肪肝所引起的消化不良进行治疗时选择胰酶肠溶胶囊，其临床疗效确切，可以有效的改善患者的临床症状，不良反应的发生率更低，安全性高。 　　【关键词】酒精性脂肪肝；多烯磷脂酰胆碱；消化不良；胰酶肠溶胶囊；治疗效果 Abstract：Objective To investigate and Analysis on alcoholic fatty liver in patients with dyspeptic patients by pancreatin enteric coated capsules in the clinical treatment effect. Method the study object is selected in May 2012 to 2014 may come to my hospital for treatment of 106 cases of alcohol fatty liver with dyspeptic patients，the clinical data were retrospectively analyzed，and were randomly divided into study group and control group，control group with conventional polyene phosphatidylcholine treatment. For patients in the study group，on the basis of the control group increased pancreatin enteric coated capsules for treatment. The results of the study group，the total efficiency is as high as 94.34%，was significantly higher than that of the control group 79.25%（P lt; 0.05）；symptom score before treatment（8.4 + 3.1）points dropped to（+ 3.4 1.1），difference is obviously superior to the control group，between group differences in the data significantly（P lt; 0.05）；adverse reaction incidence was 7.55% in the study group，significantly lower than control group（18.87%）and group data difference significant（P lt; 0.05）. Conclusion in the digestion of alcoholic fatty liver caused by bad treatment choose pancreatin enteric coated capsules，the clinical curative effect，can effectively improve the patients clinical symptoms，lower incidence of adverse reactions，safety. Keywords：alcoholic fatty liver；polyene phosphatidylcholine；dyspepsia；Pancreatin Enteric-coated Caps